GlassScriptPhysician profile
Mathew B Gavin
NPI 1063408391
$3,692.23
in general payments reported to CMS, 2019-2025
18 companies · $62.76 in 2025
The $62.76 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $2,575 · 2021: $75.83 · 2022: $144 · 2023: $162 · 2024: $144 · 2025: $62.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,486.50 | 2020 | |
| Depuy Synthes Sales INC. | $267.94 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Supreme Orthopedic Systems, LLC | $152.09 | 2019-2024 | |
| Bioventus LLC | $103.77 | 2021-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $86.38 | 2019-2020 | |
| Heron Therapeutics, INC. | $79.79 | 2022-2023 | Zynrelef |
| Stryker Corporation | $78.32 | 2019-2023 | Tornier Perform Reversed Glenoid, Tornier Perform Reversed Augmented Glenoid, Blueprint Patient Specific Instrumentation |
| Abiomed | $76.02 | 2024 | Impella |
| Pacira Therapeutics, INC. | $62.99 | 2020-2021 | |
| Wright Medical Technology, INC. | $57.58 | 2019 | |
| Fidia Pharma USA INC. | $42.87 | 2022 | |
| Embody, INC. | $42.57 | 2023 | |
| Ethicon US, LLC | $37.34 | 2019 | |
| Endo Pharmaceuticals INC. | $35.84 | 2019-2020 | |
| Becton, Dickinson and Company | $34.42 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.27 | 2022 | |
| Convatec INC. | $15.90 | 2023 | |
| Sanofi-Aventis U.S. LLC | $14.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Gavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.